Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
209 Cards in this Set
- Front
- Back
How are the biological roles of DNA/RNA different from other classes of biological molecules like proteins and carbohydrates?
|
DNA and RNA's function is the storage and transfer of information and the regulation of biochemical processes
|
|
Osborn Avery experiment
|
Treatment of R-form of penumococcus bacteria with pure DNA extracted from the S-form results in its transformation into the S-form that was inheritable.
Demonstrated that DNA was the transforming agent as well as the material responsible for transmitting genetic info from one generation to the next. |
|
Purines
|
Consists of a pyrimidine ring fused to an imidazole ring
Includes adenine and guanine |
|
Pyrimidines
|
Only consists of a six-membered nitrogen-containing ring
Includes Cytosine, Uracil (RNA), Thymine (DNA) |
|
What is the major form of DNA bases found?
|
Major form of DNA bases are in amino-keto form
|
|
What is the minor form of DNA bases found?
|
Tautomeric form due to rearrangement of the double bonds
|
|
Tautomeric form ratio
|
A small fraction of each base exists in its tautomeric form
|
|
Deoxynucleoside
|
Deoxyribose + DNA base
|
|
Nucleoside
|
Ribse + DNA base
|
|
Difference between Ribose and Deoxyribose sugars
|
At the 2` position, the deoxyribose does not have a hydroxyl group.
Ribose is less stable because the 2` hydroxyl group is attacked, leading to degradation. The deoxyribose has enhanced stability of ring structure because of 2` deoxy |
|
What is the linkage that is between the nucleotide base and the sugar?
|
N-beta-Glycosidic bond joins the Nitrogen of the base to C1` on the sugar
|
|
What are the phosphate of nucleosides derivatives of?
|
Phosphoric acid - H3PO4
|
|
What is the linkage that is between two different nucleosides?
|
Phosphodiester bonds
|
|
Deoxynucleotides
|
DNA base + deoxyribose + phosphate
OR deoxynucleoside + phosphate |
|
Where are phosphodiester bonds formed?
|
Formed between the 3` OH position of one deoxynucleotide and 5` OH of the next
|
|
What bonds create the backbone of DNA?
|
repeating Phosphodiester bonds
|
|
Oligonucleotides
|
Nucleic acids less than 50 nucleotides
|
|
Polynucleotides
|
Nucleic acids that are greater than 50 nucleotides in length
|
|
Chargoff's Rule
|
The abundance of deoxyadenosine always equaled that of thymidine and the abundance of deoxyguanosine always equalted that of deoxycytidine
|
|
How is the double helix stabilized?
|
The electrons of the adjacent base pairs interact, generating stacking forces and stabilize the helix in addition to the hydrogen bonds between the base pairs.
|
|
What are the different types of DNA conformations and which one is more prevalent?
|
A, B, and Z
The right handed B form is the most prevalent |
|
What shape is the biological active form of DNA
|
The form is superhelical created by either underwinding or overwinding the double helix.
|
|
Histones
|
Small basic proteins containing large amounts of positively charged arginine and lysine that strongly binds to negative charged phosphates on DNA to package and order the DNA into structural units called nucleosomes
|
|
Chromatin
|
The complex that includes DNA, histones, and other proteins that makes up chromosomes
|
|
Nucleosomes
|
Consist of a segment of DNA wound around a histone protein core
|
|
Mitochondrial DNA
|
A small portion of eukaryotic DNA that is located in the mitochondria.
It encodes some, but not all of the mitochondrial proteins. |
|
Structure of DNA
|
RNA chains are single-stranded
Lack the continuous helical structure of double-stranded DNA but does make stem-loop structure Uses uracil rather than thymine Sugar is a ribose |
|
Small interfering RNA (siRNA)
|
Form of RNA that is effective in reducing the expression or completely silencing specific genes
|
|
What are the essential building blocks necessary for Purine synthesis?
|
Glycine, Glutamine, Aspartate and Tetrahydrofolate.
|
|
How does Purine synthesis differ from Pyrimidine synthesis?
|
Purines begin through the construct of the rings on a sugar while Pyrimidines do not.
|
|
What is the central intermediate for Purine synthesis?
|
Inosine Monophosphate (IMP)
|
|
What is the role of glutamine in Purine synthesis?
|
Glutamine donates its amine groups to make the central intermediate during Purine synthesis
|
|
What is the role of Glycine in Purine synthesis?
|
Glycine donates its carbon and nitrogen skeletons to make the central intermediate ring in Purine synthesis
|
|
What is the role of Aspartate in Purine synthesis?
|
Aspartate donates its carbon and nitrogen skeletons to make the central intermediate ring in Purine synthesis.
|
|
What is the role of tetrahydrofolate in Purine synthesis?
|
Tetrahydrofolate is a one carbon donor that participates in the formation of the central intermediate in Purine synthesis.
|
|
What is used to make the 5 membered ring of Purines?
|
Use glycine, glutamine and tetrahydrofolate and attach it to ribose
|
|
What is used to make the 6 membered ring of Purines?
|
Use aspartate's carbon skeleton and a carbon from tetrahydrofolate to finally make IMP.
|
|
Why is the addition of glutamine to PRPP a committed step?
|
PRPP has a pyrophosphate group at C1` which is an excellent leaving group, making the molecule high reactive, therefore, once the reaction occurs, the following molecules must be made.
|
|
How many ATPs are needed to make IMP?
|
4 ATPs
|
|
What is the committed step in purine synthesis?
|
The amine group from glutamine is transfered to the C1` position of the PRPP sugar to make the amine sugar.
It is controlled by amidophosphoribosyl transferase. |
|
IMP dehydrogenase
|
Converts IMP to XMP
Requires NAD+ |
|
GMP synthase
|
Converts XMP to GMP
Requires ATP and glutamine |
|
What is needed to convert purine central intermediate IMP to GMP?
|
Requires NAD, glutamine and additional ATP
|
|
Adenylosuccinate synthase
|
Converts IMP to adenylosuccinate
Requires GTP |
|
Adenylosuccinate lyase
|
Converts Adenylosuccinate to AMP
Creates fumarate by-product |
|
What energy carriers are needed to make AMP from start to finish?
|
Need 4 ATPs + 1 GTP total
|
|
What energy carriers are needed to make GMP from start to finish?
|
Need 5 ATPs total
|
|
How do you make NDPs from NMPs?
|
Use kinases to add an additional phosphate at the 5` end
|
|
How do you make NTPs from NDPs?
|
Use nucleotide diphosphate kinases to add an additional phosphate at the 5` end
|
|
How is Adenine destroyed?
|
Adenine cannot directly be destroyed. It is converted back to AMP and then made into another purine before it can be destroyed.
|
|
How is Guanine destroyed?
|
Guanine can be converted directly to xanthine, which is converted to uric acid for excretion.
|
|
Gout
|
A disease associated with defects in purine recycling.
Dietary, genetic, use of drugs or other medical issues leads to a underexcretion of urate, leading to its crystallization in joint capsules forming Tophi masses of uric acid. It leads to acute inflammatory arthritis which begins to destroy the tissue and surrounding bones |
|
How to manage gout?
|
Managment is 2-fold.
Reduce inflammatory response using anti-inflammatory drugs and Reduce the urate levels via blockage of Xanthine oxidase |
|
How do you reduce the inflammatory response associated with Gout?
|
Use non-steroid anti-inflammatory drugs (NSAIDS)
Steroids or Colchicine to stop the destroying process of surrounding tissues. |
|
How do you reduce urate levels in the blood to manage Gout?
|
Need to block the purine pathway to stop the formation of uric acid by blocking the conversion of hypoxanthine to xanthine or the conversion of xanthine to uric acid
Two blockers used are allopurinol and oxipurinol Makes soluble allaontoin to be excreted instead of uric acid. |
|
Lesch-Nyhan Syndrome
|
A genetic disease associated with defects in purine recycling.
It is a X-linked recessive disease which causes a deficiency in hypoxanthine-guanine phosphoribosyltransferase (HPRT) Leads to hyperuricemia in the blood and build up of uric acid in the brain. Neurological problems develop like spacticity and mental retardation |
|
What does a HGPRT deficiency give rise to?
|
It causes Lesch-Nyhan Syndrome
Gives rise to: 1. Increased turnover of purines since salvage is blocked 2. increased synthesis of purines since unused PRPP stimulates the pathway - this gets degraded also 3. Hyperuricemia: Increased uric acid concentration in the blood |
|
Treating Lesh-Nyhan Disease
|
There are more complications assciated with this disease than gout.
Once crystals form in the brain, there is no way to dissolve them. Only further formation of crystals can be blocked through drugs like allopurinol |
|
How does chemotherapy block purine synthesis?
|
Rapidly dividing cells, such as cancer cells, need purine synthesis to continue growing.
Use drugs which mimic the shape of a purine building block that can also inhibit an enzyme to block purine development |
|
Azaserine
|
A chemotherapy drug that functions as a purine antagonist and glutamine analogue. It binds to the amidotransferase inhibitor and inhibits the committed step of purine synthesis from occurring.
|
|
Mycophenolate
|
Inhibits purine synthesis by blocking IMP dehydrogenase.
Used as a immunosuppressant drug. |
|
Methotrexate
|
Indirectly blocks puring biosynthesis by blocking folic acid production.
Used as an anti-cancer drug |
|
Where does Purine synthesis occur in the cell?
|
Exclusively in the Cytosol
|
|
Where does Pyrimidine synthesis occur in the cell?
|
Pyrimidine synthesis occurs in the cytosol with a portion of it occurring in the mitochondria
|
|
What is the committed step in pyrimidine synthesis?
|
It is the conversion of glutamine to carbomyl phosphate through the carbomoyl phosphate synthetase enzyme.
It takes two ATPs, a bicarbonate, and glutamine |
|
Explain the Dihydroorotate to orotate conversion in pyrimidine synthesis
|
This conversion occurs through Ubiquinone, which can be found in the mitochondria part of the ETC.
Ubiquinone is used as an electron donor for the conversion. |
|
Ubiquinone
|
Found in the ETC in the mitochondria.
Used as an electron donor in the conversion of dihydroorotate to orotate. |
|
What are the essential building blocks of pyrimidine synthesis?
|
Aspartic acid, glutamine, bicarbonate and ubiquinone
|
|
What is aspartic acid's role in pyrimidine synthesis?
|
It donates its carbon and nitrogen skeleton
|
|
What is glutamine's role in pyrimidine synthesis
|
It donate its NH2 groups
|
|
What is the role of bicarbonate in pyrimidine synthesis?
|
It donates a carbon atom
|
|
What is the role of ubiquinone in pyrimidine synthesis?
|
It is the electron acceptor to do oxidative reduction.
|
|
What is the central intermediate of pyrimidine synthesis?
|
Uridine 5`-monophosphate (UMP)
|
|
At what point does ribose attach to ring to form UMP in pyrimidine synthesis?
|
PRPP attaches to orotate
|
|
How is CTP formed from the central intermediate in pyrimidine synthesis?
|
From UMP, CTP is created using glutamine through CTP synthetase
|
|
How many energy carriers are needed to form CTP?
|
5 ATPs in total are needed
|
|
How is TTP formed from the central intermediate in pyrimidine synthesis?
|
Entirely different pathway is used because it is only created for DNA synthesis
UMP is converted to dUDP Then transfers a methyl group from N,N-methylene tetrahydrofolate using thymidylate synthetase to dUDP. |
|
How many energy carriers are needed to form TTP?
|
6 ATPs in total are needed
|
|
How many energy carriers are needed to form UTP?
|
4 ATPs in total are needed
|
|
How do you inhibit the production of TTP?
|
You target the thymidylate synthetase enzyme involved in converting dUMP to dTMP using NN-methylene tetrahydrofolate
|
|
What is the active methyl donor involved in conversion of dUMP to DTMP?
|
N6, N10-methylene tetrahydrofolate
|
|
How is the N6, N10 methylene tetrahydrofolate regenerated?
|
N6, N10 methylene tetrahydrofolate is converted to dihydrofolate when used by thymidylate synthetase for dUMP to dTMP conversion
Dihydrofolate is modified by NADPH to Tetrahydrofolate through Dihydrofolate reductase. Dihydrofolate is activated to N5,N10 methylene tetrahydrofolate by serine's addition of OH group |
|
How does F-dUMP stop DNA synthesis?
|
F-dUMP blocks conversion of dUMP to dTMP by thymidylate synthetase in dTMP production pathway
|
|
How does Aminopterine stop DNA synthesis?
|
Aminopterine blocks conversion of dihydrofolate to tetrahydrofolate by inhibiting dihydrofolate reductase
|
|
How do you inhibit the production of TTP?
|
You target the thymidylate synthetase enzyme involved in converting dUMP to dTMP using NN-methylene tetrahydrofolate
|
|
How do you inhibit the production of TTP?
|
You target the thymidylate synthetase enzyme involved in converting dUMP to dTMP using NN-methylene tetrahydrofolate
|
|
What is the active methyl donor involved in conversion of dUMP to DTMP?
|
N6, N10-methylene tetrahydrofolate
|
|
What is the active methyl donor involved in conversion of dUMP to DTMP?
|
N6, N10-methylene tetrahydrofolate
|
|
How is the N6, N10 methylene tetrahydrofolate regenerated?
|
N6, N10 methylene tetrahydrofolate is converted to dihydrofolate when used by thymidylate synthetase for dUMP to dTMP conversion
Dihydrofolate is modified by NADPH to Tetrahydrofolate through Dihydrofolate reductase. Dihydrofolate is activated to N5,N10 methylene tetrahydrofolate by serine's addition of OH group |
|
How is the N6, N10 methylene tetrahydrofolate regenerated?
|
N6, N10 methylene tetrahydrofolate is converted to dihydrofolate when used by thymidylate synthetase for dUMP to dTMP conversion
Dihydrofolate is modified by NADPH to Tetrahydrofolate through Dihydrofolate reductase. Dihydrofolate is activated to N5,N10 methylene tetrahydrofolate by serine's addition of OH group |
|
How does F-dUMP stop DNA synthesis?
|
F-dUMP blocks conversion of dUMP to dTMP by thymidylate synthetase in dTMP production pathway
|
|
How does F-dUMP stop DNA synthesis?
|
F-dUMP blocks conversion of dUMP to dTMP by thymidylate synthetase in dTMP production pathway
|
|
How does Aminopterine stop DNA synthesis?
|
Aminopterine blocks conversion of dihydrofolate to tetrahydrofolate by inhibiting dihydrofolate reductase
|
|
How does Aminopterine stop DNA synthesis?
|
Aminopterine blocks conversion of dihydrofolate to tetrahydrofolate by inhibiting dihydrofolate reductase
|
|
How do you inhibit the production of TTP?
|
You target the thymidylate synthetase enzyme involved in converting dUMP to dTMP using NN-methylene tetrahydrofolate
|
|
What is the active methyl donor involved in conversion of dUMP to DTMP?
|
N6, N10-methylene tetrahydrofolate
|
|
How is the N6, N10 methylene tetrahydrofolate regenerated?
|
N6, N10 methylene tetrahydrofolate is converted to dihydrofolate when used by thymidylate synthetase for dUMP to dTMP conversion
Dihydrofolate is modified by NADPH to Tetrahydrofolate through Dihydrofolate reductase. Dihydrofolate is activated to N5,N10 methylene tetrahydrofolate by serine's addition of OH group |
|
How does F-dUMP stop DNA synthesis?
|
F-dUMP blocks conversion of dUMP to dTMP by thymidylate synthetase in dTMP production pathway
|
|
How does Aminopterine stop DNA synthesis?
|
Aminopterine blocks conversion of dihydrofolate to tetrahydrofolate by inhibiting dihydrofolate reductase
|
|
What can pyrimidines be broken down into when being recycled?
|
Simple forms such as ammonium, carbon dioxide and water
|
|
β-aminoisobutyrate
|
Intermediate formed during the breakdown of thymine.
Used as a label to see if cells are undergoing high rates of cell division |
|
Helicase
|
Protein enzyme that separates the DNA strands and unwind the parental duplex
|
|
Werner Syndrome
|
Rare disorder characterized by premature aging
Due to deficient helicases |
|
Toposiosmerases
|
Enzymes that wind/unwind DNA
Alter the linking number of DNA by three step process 1. Cleavage of one or both strands of DNA 2. Passage of segment of DNA through enzyme through this break 3. Resealing of DNA break |
|
Topoisomerase Type I
|
Cleaves just one strand of DNA
Catalyzes the relaxation of a supercoiled DNA Thermodynamically favorable |
|
Topoisomerase Type II
|
Enzymes cleave both strands of DNA
Utilizes energy from ATP hydrolysis to add negative supercoils to DNA |
|
What is the rate of DNA replication?
|
2000 bases are incorporated per second
|
|
Primer used in DNA replication
|
Short piece of RNA that is attached, usually to lagging strand of DNA, for DNA polymerase to catalyze replication
|
|
Primase
|
Primase catalyzes the synthesis of a short RNA segments, called a primer, complementary to a ssDNA template
Primase is activated by Helicase |
|
In what direction does synthesis go in DNA replication?
|
Synthesis goes from 5` to 3`
|
|
DNA polymerase III
|
Holoenzyme
Primary enzyme complex involved in prokaryotic DNA replication Catalytic prowess: 1000 nucleotides are added per second compared to 10nucleotides/sec for DNA polymerase I (It is 1000 times faster) This is due to processivity Has proofreading capabilities that correct replication mistakes by means of exonuclease activity (3` --> 5`) |
|
Processivity
|
Measure of the average number of nucleotides added by DNA polymerase enzyme per association/disassociation with the template
|
|
DNA polymerase I
|
an enzyme that participates in the process of DNA replication in prokaryotes and also removes RNA primer
Possesses three enzymatic activities: 1. 5' -> 3' (forward) DNA polymerase activity, requiring 3' primer site and template strand 2. 3' -> 5' (reverse) exonuclease activity that mediates proofreading 3. 5' -> 3' (forward) exonuclease activity mediating nick translation during DNA repair |
|
Okazaki fragments
|
Synthesis of DNA that is produced in a 5` to 3` direction away from the fork in pieces, that is eventually joined together
|
|
DNA ligase
|
Enzyme that catalyzes the formation of phosphodiester bonds between the 3` hydroxyl group at the end of one DNA chain and the 5`-phosphate group at the end of the other strand.
Uses ATP in eukaryotes Uses NAD+ in bacteria |
|
What is the error rate of base-pairing?
|
Error rate is about 10^6
If proofreading activity is removed, the error rate increases to about 10^3 |
|
What are some of the differences between bacterial and eukaryotic DNA replication?
|
Replication is continuous in bacterial cells.
In eukaryotic cells it is done in phases. Bacterial chromosomes have a single point of origin. Eukaryotic chromosomes have multiple points of oritins at which replications begins. |
|
Poymerase δ
|
The major eukaryotic enzyme involved in DNA replication on leading and lagging strands
Exonuclease Activity goes 3` to 5` |
|
Single stranded binding proteins
|
Prevents the single strands of DNA from reassociating during replication
|
|
Telomerase
|
Enzyme that adds DNA sequence repeats ("TTAGGG") to the 3' end overhang of DNA strands in the telomere regions
Acts as a RNA-dependent DNA polymerase (like reverse transcriptase) because it contains both proteins and RNA Once long, the primase enzyme can bind and synthesize the complementary strand |
|
Xeroderma pigmentosum
|
Genetic disorder of DNA repair in which the ability to repair damage caused by ultraviolet (UV) light is deficient
|
|
Mismatch repair
|
Parental DNA strands contain methyl groups on adenine bases in specific sequences
During replication, the newly synthesized strands are not immediately methylated Unmethylated strand is repaired |
|
Benzo[a]pyrne
|
Not carcinogenic until it is oxidized
Covalently binds to guanine residues in DNA, interrupting hydrogen bonding in G-C base pairs Produced distortions of the helix |
|
Thymine dimer
|
UV light can cause two adjacent pyrimidines to form a covalent dimer
|
|
Hereditary Nonpolyposis Colorectal Cancer
|
AKA Lynch syndrome
Results from defective DNA mismatch repair Not rare (1 in 200 people develop cancer) |
|
Translocation
|
When the free ends of DNA at break points reseal with free ends of a different chromosome
|
|
Transposons
|
Segments of DNA that can move from their original position in the genome to a new location
Found in all organisms |
|
Reverse Transcriptase
|
An enzyme that uses a single-stranded RNA template to make a DNA copy
Found in retroviruses |
|
cDNA
|
Complementary DNA
The DNA copy of the RNA produced by reverse transcriptase |
|
Transcription
|
Synthesis of RNA from a DNA template
Catalyzed by a large enzyme called RNA polymerase |
|
RNA polymerase
|
Catalyzes the initiation and elongation of RNA chains
|
|
Which strand of DNA is used for transcription?
|
Copying takes placed from complementary (template/antisense) strand.
Therefore the mRNA has the same sequence of genes as the coding (sense) strand |
|
Why type of bonds are created by DNA polymerases and RNA polymerases
|
Forms ester bonds between nucleotides that base-pair with the complementary nucleotides on the DNA template
|
|
Difference between RNA and DNA polymerase
|
Unlike DNA polymerase, RNA polymerase can initiate the synthesis of new chains in the absence of primers
RNA polymerase also lacks 3` to 5` exonuclease proofreading activity |
|
Bacterial RNA polymerase
|
Single RNA polymerase transcribes DNA to generate all forms of RNA (mRNA, rRNA, and tRNA)
|
|
Eukaryotic RNA polymerase
|
Three different RNA polymerases involved in transcription.
|
|
RNA Polymerase I
|
Eykaryotic RNA polymerase that produces most of the rRNA.
It is insensitive to the effects of alpha-amanitin |
|
RNA Polymerase II
|
Eukaryotic RNA polymerase that produces mRNA
Strongly inhibited by alpha-amanitin, even under low concentrations of poison |
|
RNA Polymerase III
|
Eukaryotic RNA polymerase that produces small RNAs like tRNA and 5S rRNA
Inhibited by alpha-amanitin only under high concentrations |
|
alpha-amanitin
|
Poison that binds tightly to RNA polymerase II.
Blocks the elongation phase of RNA synthesis Higher concentrations of the poison also inhibits RNA polymerase III |
|
Cis acting activating regions
|
The promotor region is on the same strand of DNA that is being transcribed
|
|
Trans acting proteins
|
Proteins that bind to promotor DNA sequences. They are not on the same strand.
|
|
Promotor region
|
Areas that are on the DNA that shows which genes to transcribe and where RNA polymerase should start transcribing them
|
|
Two basic markers for where transcription should start in Prokaryotes
|
TATA/Pribnow box (-10)
-35 base pair consensus sequence |
|
How is frequency of transcription controlled
|
Controlled by regulatory sequences within the promotor and enhancers
|
|
Promotor-proximal elements
|
Interact with proteins that stabilize RNA polymerase binding to the promotor to help with rapid transcription
|
|
Eukaryotic promotors
|
TATA box present, but is more downstream (-20 to -30)
G-C rich sequence found at -40 CAAT box at -110 |
|
General Transcription Factors
|
AKA Basal factors
Bind to TATA box and facilitate the binding of RNA polymerase II to transcribe mRNA |
|
TFIIH
|
Unwinds DNA for either transcription or DNA repair
Acts as an ATP-dependent DNA helicase |
|
Transcription factors that act in the site of promotion
|
These generally work on many genes
|
|
Transcription factors that act at specific genes
|
Are gene specific transcription factors
|
|
What signals terminate transcription
|
Formation of hairpin loop on RNA preceding a number of Uracil residues
Rho factors associate with RNA polymerase and leads to termination |
|
Rho factors
|
Rho factors are ATP-dependent helicases that associate with RNA polymerase and leads to termination
It pulls RNA away from the RNA polymerase |
|
What leads to the formation of hairpin loops?
|
Palindrome sequences cause the RNA to fold back on itself forming the loop
|
|
Operon
|
A region of DNA that controls the process of transcription
|
|
Lac Operon
|
Repressor protein, encoded by promotor, blocks the promotion of genes to be transcribed. It prevents RNA polymerase from transcribing these genes
An inducer binds to the repressor protein, causing it to dissociate. RNA polymerase can now recognize the promotor for genes. |
|
Cistron
|
A region of DNA that encodes a single polypeptide chain
|
|
Repressor Protein
|
Repressor protein, encoded by promotor, blocks the promotion of genes to be transcribed. It prevents RNA polymerase from transcribing these genes
|
|
Inducer
|
A stimulator that binds to the repressor protein of lac operons, causing it to dissociate
|
|
Capping modification
|
Synthesized by RNA polymerase II
5` terminal end is modified such that a GTP is attached in a 5` to 5` linkage and methylation occurs at guanine and 2`C of ribose It decreases the rate of degradation and serves as a recognition site for the binding of mature mRNA to ribosomes for translation |
|
Poly(A) Tail
|
Modification of RNA where 250 adenine nucleotides are added to the 3` end by poly(A) polymerase
|
|
Removal of Introns
|
Modification of pre-mRNA where large regions are excised and the exons are spliced together.
It is carried out by spliceosomes |
|
Spliceosomes
|
Assemblies of proteins and small RNA molecules (Ribozyme) that carry out splicing of Exons
|
|
Rifampicins
|
Antibiotic that can inhibit transcription.
Binds to a pocket in RNA polymerase to block transcription |
|
Actinomycin D
|
Antiobiotic that inhibits transcription
It slips in between base pairs (intercalation) and binds tightly to DNA, thereby preventing transcription |
|
Stop Codons
|
UAA, UAG, UGA
|
|
Degenerative genetic code
|
More than one codon can code for the same amino acid
|
|
Synonyms
|
Codons that specify the same amino acid
|
|
Point mutation
|
A single base change
|
|
Silent mutation
|
A change that specifies the same amino acid
|
|
Missense mutation
|
A change that specifies a different amino acid
|
|
Nonsense mutation
|
A change that produces a stop codon
|
|
Insertion mutation
|
An addition of one or more bases
|
|
Deletion mutation
|
A lost of one or more bases
|
|
Sickle cell anemia
|
Caused by a point mutation of GAG from GTG
|
|
Frame-shift mutations
|
Subclass of insertion/deletion mutation
When bases are added or removed, it causes a shift in the reading frame, therefore all the codons will be shifted |
|
Anticodon
|
Loop on tRNA that is complementary to mRNA
|
|
5` end of tRNA
|
Phosphorylated area
Has an activated amino acid |
|
3` end of tRNA
|
Activated amino acid is attached to the -OH group of 3`` end
|
|
Wobble Hypothesis
|
Some tRNA molecules can recognize more than one codon
|
|
Hypoxanthine
|
Base found in anticodon (it is the first base of anticodon to match last base in codon)
Allows wobble base-pairs to form It can bind to adenine, cytosine or uracil Therefore, one tRNA molecule can base pair with three different codons |
|
Aminoacyl-tRNA synthetases
|
Enzymes that attach amino acids to their tRNA
Twenty different enzymes exist, one for each amino acid |
|
dHow does aminoacyl-tRNA synthetases chose tRNA partners?
|
Anticodons
Acceptor stem - position that contains amino acid at the end of the loop Other Unique features like unusual bases and placement of bases |
|
Ribosomal subunit
|
Large subunit (50S)
Small subunit (30S) Together form 70S |
|
Initiation of Translation
|
Involves the formation of a complex composed of methionyl-tRNAiMet, mRNA and a ribosome
Initiator tRNA binds to 30S part of ribosome. GTP and initiation factors are attached to activate this. mRNA binds |
|
P Site
|
Peptidyl site on ribosome
|
|
A site
|
Aminoacyl site on the ribosome
|
|
Shine-Delgarno sequence
|
Protein synthesis begins with the interaction of 30S subunit and mRNA through this sequence.
|
|
Differences between Eukaryotic and Prokaryotic Initiation of Protein Synthesis
|
Eukaryotic
1. Binding of mRNA to small ribosomal subunit is through 5` cap of mRNA 2. First amino acid is methionine 3. Initiation factors are elFs 4. Ribosomes are 80S (40S and 60S) Prokaryotes 1. Binding of mRNA to small ribosomal subunits is through Shine-Dalgarno sequence 2. First amino acid is formyl-methionine 3. Initiation factors are IFs 4. Ribosomes are 70S (30S and 50S) |
|
Peptidyltransferase
|
rRNA of large ribosomal subunit catalyzes the formation of the peptide bond in translation of mRNA
|
|
Translocation
|
Uncharged tRNA moves from the P site and is release from the ribosome
|
|
Ribosomal release factor
|
A protein that resembles tRNA that recognizes stop codons and terminates translation
|
|
Polysomes
|
A group of Ribosomes that simultaneously translate a single mRNA
|
|
Chaperones
|
Bind to Nascent Polypeptide chains that protect against misfolding.
|
|
Post-translation modification
|
Initial methionine is removed by protease
Cleavages of proteins to activate (proinsulin to insulin) Modified through phosphorylations, methylations, carboxylations, etc to change the behavior of the protein |
|
Proteins synthesized on polysomes in the cytosol
|
After they are release from ribosomes, they remain in the cytosol, they they carry out their functions
|
|
Proteins synthesized on cytosolic ribosomes
|
Enter organelles, such as mitochondria or nuclei
|
|
Proteins synthesized on ribosomes bound to RER
|
Proteins are destined for secretion or for incorporation in organelles or cellular membranes
|
|
Chromatin Remodeling
|
Positive charge from amino group of lysine is acetylated, removing its charge, thereby reducing the electrostatic forces between histones and DNA.
Makes it easier for DNA to unwind |
|
Methylation of 5` cytosine
|
Means of regulation of DNA to turn transcription and therefor translation off.
|
|
Streptomycin
|
Antibiotic that inhibits initiation of translation and causes the misreading of mRNA in prokaryotes
|
|
Tetracycline
|
Antiobiotic that binds to the 30S subunit and inhibits the binding of amino-acyl-tRNAs in prokaryotes
|
|
Chloramphenicol
|
Antiobiotic that inhibits the peptidyl transferase activity of the 50S ribosomal subunit in prokaryotes
|
|
Cycloheximide
|
Antibiotic that inhibits translocation in eukaryotes
|
|
Erythromycin
|
Antibiotic that binds to 50S subunit and inhibits translocation in prokaryotes
|
|
Puromycin
|
Antibiotic that causes premature chain termination during translation by acting as an analog of aminoacyl-tRNA in prokaryotes and eukaryotes
|
|
Ciprofloxacin
|
Interferes with the breakage and rejoining of DNA chains
|
|
Camptothecin
|
Antitumor agen that inhibits human toposiomerase I by stabilizing the form of the enzyme covalently linked to DNA
|
|
Diphtheria Toxin
|
Toxin that blocks protein synthesis in eukaryotes by inhibiting translocation
|